Contrasting Dynatronics Corporation (DYNT) & Invivo Therapeutics Holdings Corp (NVIV)

Dynatronics Corporation (NASDAQ: DYNT) and Invivo Therapeutics Holdings Corp (OTCMKTS:NVIV) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their analyst recommendations, dividends, profitability, valuation, earnings, institutional ownership and risk.

Earnings and Valuation

This table compares Dynatronics Corporation and Invivo Therapeutics Holdings Corp’s revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio EBITDA Earnings Per Share Price/Earnings Ratio
Dynatronics Corporation $32.72 million 0.26 -$261,530.00 ($1.24) -1.90
Invivo Therapeutics Holdings Corp N/A N/A -$25.77 million N/A N/A

Dynatronics Corporation has higher revenue and earnings than Invivo Therapeutics Holdings Corp.

Insider and Institutional Ownership

18.0% of Dynatronics Corporation shares are owned by institutional investors. 47.6% of Dynatronics Corporation shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Profitability

This table compares Dynatronics Corporation and Invivo Therapeutics Holdings Corp’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Dynatronics Corporation -5.47% -88.57% -9.59%
Invivo Therapeutics Holdings Corp N/A -118.45% -96.82%

Analyst Ratings

This is a breakdown of current ratings and recommmendations for Dynatronics Corporation and Invivo Therapeutics Holdings Corp, as provided by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Dynatronics Corporation 0 0 0 0 N/A
Invivo Therapeutics Holdings Corp 0 1 0 0 2.00

Invivo Therapeutics Holdings Corp has a consensus price target of $6.00, indicating a potential upside of 263.64%. Given Invivo Therapeutics Holdings Corp’s higher probable upside, analysts plainly believe Invivo Therapeutics Holdings Corp is more favorable than Dynatronics Corporation.

Summary

Dynatronics Corporation beats Invivo Therapeutics Holdings Corp on 6 of the 8 factors compared between the two stocks.

About Dynatronics Corporation

Dynatronics Corporation is a manufacturer and distributor of physical medicine products. The Company’s products include a line of medical equipment for physical medicine applications, including therapy devices, medical supplies and soft goods, treatment tables and rehabilitation equipment. Its products are used by physical therapists, chiropractors, sports medicine practitioners, podiatrists, physicians and other physical medicine professionals. Its physical medicine products include therapeutic modalities, such as Dynatron Solaris, including electrotherapy and thermal therapy, and 25 Series, including electrotherapy and ultrasound; manufactured capital products, including traction systems and wood furniture; manufactured supplies, including cold packs, straps, wedges, bolsters and mats; distributed capital products, including hydrotherapy, weight training equipment and pilates, and distributed supplies, including clinical accessories, sports med and taping products, lotions and gels.

About Invivo Therapeutics Holdings Corp

InVivo Therapeutics Holdings Corp., formerly Design Source, Inc., is a research and clinical-stage biomaterials and biotechnology company. The Company is engaged in developing and commercializing biopolymer-scaffolding devices for the treatment of spinal cord injuries (SCI). The Company’s approach to treating acute SCIs is based on its investigational Neuro Spinal Scaffold implant, an investigational bioresorbable polymer scaffold that is designed for implantation at the site of injury within a spinal cord contusion and is intended to treat acute spinal cord injury. The Neuro-Spinal Scaffold consists of biocompatible and bioresorbable polymers, which include poly lactic-co-glycolic acid (PLGA) and Poly-L-Lysine (PLL). The Company is also evaluating other technologies and therapeutics that may be complementary to its development of the Neuro-Spinal Scaffold implant. The Company has a clinical development program for acute SCI and a preclinical development program for chronic SCI.

Receive News & Ratings for Dynatronics Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dynatronics Corporation and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply